Mostrando 3 resultados de: 3
Filtros aplicados
Subtipo de publicación
Article(3)
Área temáticas
Enfermedades(3)
Medicina y salud(1)
Problemas sociales y servicios a grupos(1)
Salud y seguridad personal(1)
Área de conocimiento
Medicina interna(3)
Origen
scopus(3)
Efficacy and safety of levoketoconazole in the treatment of endogenous Cushing's syndrome (SONICS): a phase 3, multicentre, open-label, single-arm trial
ArticleAbstract: Background: Levoketoconazole is a ketoconazole stereoisomer in development for treatment of Cushing'Palabras claves:Autores:Biller B.M.K., Cohen F., Elenkova A., Feelders R.A., Fleseriu M., Geer E.B., Greenman Y., Pivonello R., Richard J. Auchus, Salvatori R., Witek P.Fuentes:scopusEfficacy and safety of osilodrostat in patients with Cushing's disease (LINC 3): a multicentre phase III study with a double-blind, randomised withdrawal phase
ArticleAbstract: Background: Cushing's disease is a rare endocrine disorder characterised by cortisol overproductionPalabras claves:Autores:Bertagna X., Biller B.M.K., Findling J.W., Fleseriu M., Gu F., Kim J.H., Lacroix A., Laplanche A., Lee E.J., Leelawattana R., Newell-Price J., O'Connell P., Pedroncelli A.M., Pivonello R., Richard J. Auchus, Shimatsu A., Tauchmanova L.Fuentes:scopusLevoketoconazole: a novel treatment for endogenous Cushing's syndrome
ArticleAbstract: Introduction: Endogenous Cushing’s syndrome (CS) is a rare, life-threatening endocrine disorder thatPalabras claves:cortisol, Cushing’s disease, Cushing’s syndrome, Ketoconazole, levoketoconazole, medical therapy, steroidogenesis inhibitorAutores:Biller B.M.K., Fleseriu M., Pivonello R., Richard J. Auchus, Salvatori R., Zacharieva S.Fuentes:scopus